Salvia BioElectronics (Series B)
Funding Details
Awarder
RSS - techfundingnews.com
Date Award
May 27, 2025
Vertical
Medtech
Funding URL
View Funding Page
Funding Amount
$60,000,000
Company Info
Founding Year
2017
Traction
Salvia has raised over $90 million in total funding and is advancing clinical development with the support of leading investors.
Founders
Hubert Martens, Daniel Schobben, Wim Pollet
Market
Chronic migraine treatment
Location
UK
Coinvestors
Innovation Industries, Invest-NL, EIC Fund, Inkef, Panakès Partners, SHS Capital, Dolby Family Ventures, BOM, Thuja Capital
Company Description

Salvia BioElectronics is a clinical-stage medical device company pioneering neuromodulation therapy for chronic migraine patients. Their ultra-thin implant targets key nerves involved in migraine, aiming to reduce both the frequency and intensity of attacks.

Links
Website
Back to HomeBack to Medtech DealsView Funding Announcement